Alzheimer’s Disease
Latest News in Alzheimer’s Disease
November 20, 2024
Negative Effect of Deferiprone Points to Impact of Iron Lowering in Alzheimer Disease
Over a 12-month treatment period, patients on deferiprone demonstrated decreased blood ferritin and hippocampal QSM but caused accelerated cognitive decline and increased regional brain atrophy.
November 20, 2024
Use of a “Hearable” Could Predict Early Alzheimer’s Disease – Inside Precision Medicine
November 19, 2024
Alzheimer’s: Nasal spray may clear toxic plaques, delay disease – Medical News Today
750 Active Alzheimer’s Disease Clinical Trials
Source: clinicaltrials.gov
LOCATE
CLINICAL TRIALS
BROWSE
FDA-approved DRUGS